veeva.com 1 CUSTOMER STORY The opinions stated herein are those of the writers, and not necessarily the opinion of Endo Pharmaceuticals Inc. or its affiliates. Even for biopharmas with strong processes and a quality mindset, validation can be fraught with risk and inefficiency. Scope creep can happen when teams don’t establish clear expectations at the beginning of a new project. Testing and documentation can become cumbersome, trapping teams in an endless cycle of validation that stifles new features and innovation. The IT team at Endo Pharmaceuticals Inc. (Endo) knows this firsthand. After their first Veeva Vault implementation, Gregory Rosen, executive director of IT , and Joanna Ollendorff, associate director, computer systems validation, saw an opportunity to make the validat

Join for free to read